Watch this engaging program on the evolving role of asparaginase therapies in acute lymphocytic leukemia (ALL) and lymphoblastic lymphoma (LBL). Developed specifically for oncology nurses who care for adolescent, young adult, and adult patients, this program will highlight best practices in asparaginase therapy and strategies for monitoring for adverse events such as hypersensitivity reactions and silent inactivation.

Provided by MediCom Worldwide, Inc.
This activity is supported by an independent medical education grant from Jazz Pharmaceuticals